MARCHEGIANI, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 10.934
NA - Nord America 10.001
AS - Asia 7.352
SA - Sud America 1.096
AF - Africa 244
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 29.658
Nazione #
US - Stati Uniti d'America 9.666
RU - Federazione Russa 4.395
SG - Singapore 2.848
CN - Cina 2.251
GB - Regno Unito 1.781
IT - Italia 1.357
BR - Brasile 897
DE - Germania 802
VN - Vietnam 658
HK - Hong Kong 593
SE - Svezia 578
FR - Francia 517
IE - Irlanda 517
FI - Finlandia 344
KR - Corea 231
CA - Canada 220
IN - India 147
JP - Giappone 137
NL - Olanda 129
UA - Ucraina 97
ES - Italia 88
MX - Messico 85
BD - Bangladesh 67
AR - Argentina 64
TR - Turchia 60
PL - Polonia 58
NG - Nigeria 54
ID - Indonesia 50
IQ - Iraq 48
ZA - Sudafrica 47
PK - Pakistan 45
CZ - Repubblica Ceca 43
AT - Austria 40
BE - Belgio 30
VE - Venezuela 30
LT - Lituania 29
EC - Ecuador 28
TG - Togo 27
MA - Marocco 26
UZ - Uzbekistan 23
CL - Cile 21
CO - Colombia 20
AU - Australia 19
PH - Filippine 19
TN - Tunisia 19
AZ - Azerbaigian 18
SA - Arabia Saudita 18
AE - Emirati Arabi Uniti 17
BJ - Benin 17
JO - Giordania 17
EG - Egitto 16
CH - Svizzera 15
LV - Lettonia 14
PY - Paraguay 14
SI - Slovenia 12
IR - Iran 11
RO - Romania 11
IL - Israele 10
KE - Kenya 10
NP - Nepal 10
PE - Perù 10
KG - Kirghizistan 9
PT - Portogallo 9
GR - Grecia 8
JM - Giamaica 8
KZ - Kazakistan 8
OM - Oman 8
AL - Albania 7
MY - Malesia 7
BG - Bulgaria 6
HR - Croazia 6
LB - Libano 6
NO - Norvegia 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
DK - Danimarca 5
HU - Ungheria 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
BO - Bolivia 4
ET - Etiopia 4
GA - Gabon 4
NZ - Nuova Zelanda 4
QA - Qatar 4
RS - Serbia 4
SN - Senegal 4
UG - Uganda 4
AM - Armenia 3
CR - Costa Rica 3
DZ - Algeria 3
KH - Cambogia 3
KW - Kuwait 3
LU - Lussemburgo 3
NI - Nicaragua 3
PA - Panama 3
PR - Porto Rico 3
TW - Taiwan 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
Totale 29.614
Città #
Moscow 1.621
Singapore 1.546
Southend 1.388
Ashburn 1.326
Chandler 1.074
Dallas 1.003
San Jose 991
Hong Kong 582
Verona 530
Dublin 505
Beijing 397
Munich 391
Woodbridge 351
The Dalles 317
Jacksonville 312
New York 300
Ho Chi Minh City 226
Los Angeles 203
Houston 197
Ann Arbor 185
Helsinki 175
Jinan 156
Lawrence 155
Princeton 155
Hanoi 154
Wilmington 140
Tokyo 115
Nanjing 112
Shenyang 110
Redmond 90
São Paulo 90
Montréal 89
Santa Clara 87
Redondo Beach 86
Buffalo 78
Hebei 78
Turku 76
London 73
Orem 73
Columbus 72
Council Bluffs 71
Milan 69
Tianjin 65
Bologna 61
Sindelfingen 61
Haikou 58
Chennai 56
Seattle 54
Hangzhou 50
Stockholm 49
Frankfurt am Main 48
Guangzhou 48
Warsaw 47
Abuja 46
Chicago 46
Mcallen 46
Changsha 45
Montreal 45
Ningbo 45
Denver 43
Toronto 43
Rome 42
Atlanta 41
Taiyuan 41
San Francisco 40
Seoul 40
Fairfield 39
Amsterdam 37
Zhengzhou 37
Brooklyn 36
Redwood City 36
Rio de Janeiro 35
Taizhou 35
Brno 34
Johannesburg 33
Poplar 33
Washington 33
Jiaxing 32
Nanchang 32
Brussels 30
Lancaster 30
Belo Horizonte 29
Vienna 28
Haiphong 27
Lomé 27
Mexico City 27
Da Nang 26
Phoenix 26
Falkenstein 25
Tashkent 22
Lanzhou 21
Nuremberg 21
Lappeenranta 20
Querétaro 20
Ankara 19
Fuzhou 19
Jakarta 19
Baghdad 18
Manchester 18
Meda 18
Totale 17.851
Nome #
Risk assessment for pancreatic fistula after pancreaticoduodenectomy with preoperative computed tomography 449
APPLICAZIONE DEI CRITERI RADIOLOGICI DI FUKUOKA NELLO STUDIO DEGLI IPMN DEL PANCREAS: È POSSIBILE DISTINGUERE GLI IPMN CON DISPLASIA DI GRADO ALTO-MODERATO DA QUELLI DI BASSO GRADO? 333
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA) 302
Genomic characterization of hepatoid tumors: context matters 260
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 246
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 244
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 238
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 237
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 233
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 222
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 221
A root-cause analysis of mortality following major pancreatectomy 221
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 217
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 217
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 216
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 215
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 214
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 213
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 211
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 208
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 208
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 204
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 199
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 194
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 192
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 192
Pancreatic Hepatoid Carcinoma: A Review of the Literature 191
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 190
Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings 189
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 188
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 188
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 186
Results of a surveillance protocol for pancreatic BD-IPMNs 185
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 184
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 182
An unforeseeable adverse event during ERCP 179
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 179
Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma. 177
Serous Cystic Neoplasms 176
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 176
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS) Design and International External Validation 176
Imaging after pancreatic surgery: normal post-operative findings, early and late complications with emphasis on CT imaging 175
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 175
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 175
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 175
Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS) 174
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 174
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 174
Minimally invasive pancreatic surgery - a review 173
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 173
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 173
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 173
Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers 173
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data 173
Branch Duct Intraductal Papillary Mucinous Neoplasms: Recommendations for Follow-Up and Surgery 171
Pancreaticojejunostomy after pancreaticoduodenectomy: Suture material and incidence of post-operative pancreatic fistula 171
Correlation between resection margin involvement and CT patterns of recurrence of pancreatic adenocarcinoma after surgery 169
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 168
Non-inferiority of open passive drains compared with closed suction drains in pancreatic surgery outcomes: A prospective observational study 168
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 168
Acute pancreatitis after pancreatoduodenectomy: A prospective study of diffusion-weighted magnetic resonance imaging, serum biomarkers, and clinical features 167
Endoscopic Ultrasound Features Associated with Malignancy and Aggressiveness of Nonhypovascular Solid Pancreatic Lesions: Results from a Prospective Observational Study 167
Use of an intraoperative wound protector to prevent surgical-site infection after pancreatoduodenectomy: randomized clinical trial 167
Cystic Neoplasm of the Pancreas 166
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 166
TC in urgenza in pazienti sottoposti a chirurgia del pancreas: correlazione tra complicanze e tampone rettale o faringeo pre-operatorio 166
The management of intraductal papillary mucinous neoplasms of the pancreas 165
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 164
The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis 163
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 162
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 162
Dislocation of intra-abdominal drains after pancreatic surgery: results of a prospective observational study 162
CT patterns of recurrence of pancreatic adenocarcinoma after surgery: is there a correlation with resection margin involvement? 161
Postoperative Serum Hyperamylasemia (POH) Adds Sequential Value to the Fistula Risk Score (FRS) in Predicting Pancreatic Fistula after Pancreatoduodenectomy 161
CT texture analysis of ductal adenocarcinoma downstaged after chemotherapy 160
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 160
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 160
High-risk Pancreatic Anastomosis vs. Total Pancreatectomy after Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis 160
ASO Visual Abstract: Surgery for IPMN of the Pancreas—Preoperative Factors Tipping the Scale of Decision-Making 158
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 158
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 157
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 156
Quantitative Assessment of Pancreatic Texture Using a Durometer: A New Tool to Predict the Risk of Developing a Postoperative Fistula 156
Clinical impact of the updated international postoperative pancreatic fistula definition in distal pancreatectomy 156
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) 156
Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy 155
Association between pancreatic intraductal papillary mucinous neoplasms and extrapancreatic malignancies 155
Implementation of a strategic preoperative surgical meeting to improve the level of care at a high-volume pancreatic center: a before-after analysis of 1000 consecutive cases 155
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 155
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? 154
401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience 154
Prevent Pancreatic Fistula after Pancreatoduodenectomy: Possible Role of Ultrasound Elastography 153
European evidence-based guidelines on pancreatic cystic neoplasms 153
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 153
Either High or low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum Of Pancreas-specific Complications After Pancreatoduodenectomy 152
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial 152
Preoperative fecal elastase-1 (FE-1) adds value in predicting post-operative pancreatic fistula: not all soft pancreas share the same risk - A prospective analysis on 105 patients 151
Importance of main pancreatic duct dilatation in IPMN undergoing surveillance 150
Standards for reporting on surgery for chronic pancreatitis: a report from the International Study Group for Pancreatic Surgery (ISGPS) 150
Totale 18.537
Categoria #
all - tutte 98.689
article - articoli 90.927
book - libri 0
conference - conferenze 4.665
curatela - curatele 0
other - altro 695
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.402
Totale 197.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021228 0 0 0 0 0 0 0 0 0 38 109 81
2021/20221.253 112 298 41 124 42 30 22 87 56 26 88 327
2022/20233.106 199 392 267 510 220 773 72 218 334 23 62 36
2023/20241.948 70 158 178 199 213 340 116 152 26 83 299 114
2024/20254.753 213 211 184 754 265 192 380 263 673 299 460 859
2025/202613.978 925 645 1.049 2.430 3.849 951 1.218 820 1.282 809 0 0
Totale 29.987